5 Key Points About Healthcare Policy Under the Trump Administration
Donald Trump's election stunned many and made the prospect of Obamacare being repealed almost a certainty. Here's a look at 5 key points in Trump’s healthcare reform proposals.
Donald Trump’s election stunned many voters, and as recently as October 25, speakers at America’s Health Insurance Plans’ National Conference on Medicare
The surprise outcome of the election has made many reevaluate the future of healthcare in the United States. Now that the election is over, here’s a look at 5 key points in Trump’s healthcare reform proposals.
1. Goodbye, Affordable Care Act (ACA)
While it is still unclear if Republicans and Trump will go for a
Trump ran on a platform of repeal and replace, and Republicans have been promising the same thing for years.
UPDATE, 11/11, 5:28 pm: In an
2. Paul Ryan’s “A Better Way” plan
The House Speaker, who is expected to be re-elected to the position, has
A piece in JAMA Internal Medicine that was published just before Election Day pointed out that there is overlap between Trump’s healthcare reform plan and Ryan’s proposal. While Trump’s plan is less detailed, 5 of his 7 items appear in Ryan’s plan.
3. Expanded use of health savings accounts (HSAs)
This is one of those items on both Trump’s and Ryan’s plans. Republicans are fans of increased use of HSAs, and it had been part of the ACA repeal
In an analysis of Trump’s healthcare proposals,
4. Selling insurance across state lines
Trump
The proposal to sell across state lines is based on the idea that being able to do so will lessen regulatory hurdles and decrease administrative burdens, while lowering the cost of coverage. Ryan also included purchasing coverage across state lines in his "A Better Way" policy paper.
5. Various other healthcare changes
Trump’s agenda includes reforming the FDA “to put greater focus on the need of patients for new and innovative medical products.” The FDA has already been making efforts to speed up the approval process to get medications to market faster.
Trump’s election resulted in biotech and pharma stocks increasing the day after, and this will likely be viewed as more good news for these companies.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025